General Information
Version
4.4
Revision date
2026-04-15
Product name
Casco Cascol Polyurethane
1.2.1 Relevant identified uses
Sealant/adhesive, Polyurethane coating
supplier name
Sika Norge AS
Emergency telephone
22 59 13 00
Icons in SDS
Company Information
company name
Sika Norge AS
e-mail address of the competent person responsible for the Safety Data Sheet
kundeservice@no.sika.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H332 Harmful if inhaled. H334 May cause allergy or asthma symptoms or brea- thing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure. P101 If medical advice is needed, have product
Precautionary statements
container or label at hand. P102 Keep out of reach of children.
Prevention
P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe mist or vapours. P271 Use only outdoors or in a well-ventilated area. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/ doctor if you feel unwell. P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local regulation.
Hazardous Ingredients
aromatic isocyanate-prepolymer 4,4`-Methylenediphenyl diisocyanate, oligomers 1,2-Ethanediamine, polymer with 1,1'-methylenebis[4-isocyanatobenzene], methyloxirane and oxirane
Additional information
"As from 24 August 2023 adequate training is required before industrial or pro- fessional use." Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to stan- dard EN 14387) is used.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have en- docrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulati- on (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Eye irritation, Category 2 H319: Causes serious eye irritation. Respiratory sensitisation, Category 1 H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Specific target organ toxicity - single ex- H335: May cause respiratory irritation. posure, Category 3, Respiratory system Specific target organ toxicity - repeated H373: May cause damage to organs through pro- exposure, Category 2 longed or repeated exposure.